tiprankstipranks
Trending News
More News >
Actuate Therapeutics, Inc. (ACTU)
NASDAQ:ACTU
US Market

Actuate Therapeutics, Inc. (ACTU) Financial Statements

Compare
24 Followers

Actuate Therapeutics, Inc. Financial Overview

Actuate Therapeutics, Inc.'s market cap is currently $159.45M. The company's EPS TTM is $-1.406; its P/E ratio is -5.80; Actuate Therapeutics, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22
Currency in USD

Actuate Therapeutics, Inc. Earnings and Revenue History

Actuate Therapeutics, Inc. Debt to Assets

Actuate Therapeutics, Inc. Cash Flow

Actuate Therapeutics, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.